Department of Radiation Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China.
Department of Medical Physics and Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Oncol Rep. 2018 Mar;39(3):912-920. doi: 10.3892/or.2018.6217. Epub 2018 Jan 16.
The DNA-dependent protein kinase (DNA-PK) complex plays a pivotal role in non-homologous end-joining (NHEJ) repair. We investigated the mechanism of NU7441, a highly selective DNA-PK inhibitor, in NHEJ-competent mouse embryonic fibroblast (MEF) cells and NHEJ-deficient cells and explored the feasibility of its application in radiosensitizing nasopharyngeal carcinoma (NPC) cells. We generated wild-type and DNA-PKcs-/- MEF cells. Clonogenic survival assays, flow cytometry, and immunoblotting were performed to study the effect of NU7441 on survival, cell cycle, and DNA repair. NU7441 profoundly radiosensitized wild-type MEF cells and SUNE-1 cells, but not DNA-PKcs-/- MEF cells. NU7441 significantly suppressed radiation-induced DSB repair post-irradiation through unrepaired and lethal DNA damage, the cell cycle arrest. The effect was associated with the activation of cell cycle checkpoints. The present study revealed a mechanism by which inhibition of DNA-PK sensitizes cells to irradiation suggesting that radiotherapy in combination with DNA-PK inhibitor is a promising paradigm for the management of NPC which merits further investigation.
DNA 依赖性蛋白激酶 (DNA-PK) 复合物在非同源末端连接 (NHEJ) 修复中发挥着关键作用。我们研究了高度选择性的 DNA-PK 抑制剂 NU7441 在具有 NHEJ 功能的小鼠胚胎成纤维细胞 (MEF) 和 NHEJ 缺陷细胞中的作用机制,并探讨了其在放射增敏鼻咽癌 (NPC) 细胞中的应用的可行性。我们生成了野生型和 DNA-PKcs-/- MEF 细胞。通过集落形成存活实验、流式细胞术和免疫印迹分析,研究了 NU7441 对存活、细胞周期和 DNA 修复的影响。NU7441 可显著增敏野生型 MEF 细胞和 SUNE-1 细胞的放射敏感性,但对 DNA-PKcs-/- MEF 细胞没有作用。NU7441 可通过未修复和致死性的 DNA 损伤、细胞周期阻滞来显著抑制照射后 DSB 的修复。这种作用与细胞周期检查点的激活有关。本研究揭示了抑制 DNA-PK 可使细胞对辐射敏感的机制,提示放疗联合 DNA-PK 抑制剂是 NPC 治疗的一种很有前途的模式,值得进一步研究。